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Objectives: To assess the effectiveness of implementing guidelines, coupled with individual feedback, on
antibiotic prescribing behaviour of primary care physicians in Switzerland.
Methods: One hundred and forty general practices from a representative Swiss sentinel network of primary care
physicians participated in this cluster-randomized prospective intervention study. The intervention consisted of
providing guidelines on treatment of respiratory tract infections (RTIs) and uncomplicated lower urinary tract
infections (UTIs), coupled with sustained, regular feedback on individual antibiotic prescription behaviour during
2 years. The main aims were: (i) to increase the percentage of prescriptions of penicillins for all RTIs treated with
antibiotics; (ii) to increase the percentage of trimethoprim/sulfamethoxazole prescriptions for all uncomplicated
lower UTIs treated with antibiotics; (iii) to decrease the percentage of quinolone prescriptions for all cases of exa-
cerbated COPD (eCOPD) treated with antibiotics; and (iv) to decrease the proportion of sinusitis and other upper
RTIs treated with antibiotics. The study was registered at ClinicalTrials.gov (NCT01358916).
Results: While the percentage of antibiotics prescribed for sinusitis or other upper RTIs and the percentage of
quinolones prescribed for eCOPD did not differ between the intervention group and the control group, there
was a significant increase in the percentage of prescriptions of penicillins for all RTIs treated with antibiotics
[57% versus 49%, OR¼1.42 (95% CI 1.08–1.89), P¼0.01] and in the percentage of trimethoprim/sulfamethoxa-
zole prescriptions for all uncomplicated lower UTIs treated with antibiotics [35% versus 19%, OR¼2.16 (95%
CI 1.19–3.91), P¼0.01] in the intervention group.
Conclusions: In our setting, implementing guidelines, coupled with sustained individual feedback, was not able
to reduce the proportion of sinusitis and other upper RTIs treated with antibiotics, but increased the use of recom-
mended antibiotics for RTIs and UTIs, as defined by the guidelines.
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Introduction
Antibiotic resistance is increasing rapidly worldwide. While
increasing resistance rates were initially mainly described in the
hospital setting, resistant microorganisms such as penicillin-
resistant Streptococcus pneumoniae, community-acquired MRSA
and Escherichia coli or Klebsiella spp. producing ESBLs are increas-
ingly observed in the ambulatory setting. It has been shown pre-
viously at the population level that the volume of outpatient
antibiotic use in a given area is significantly associated with resist-
ance rates in that area,1 and even that community antibiotic use
may influence resistance rates in the hospital.2 In addition,
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several reports described the association between antibiotic use
in primary care and the development of resistance in individual
patients.3,4 In ambulatory medicine, antibiotics are most com-
monly prescribed for respiratory tract infections (RTIs).1,5
Broad-spectrum agents are more likely to be prescribed for this
indication than narrow-spectrum agents.5 This is especially men-
acing as, besides the volume of antibiotics prescribed, the spec-
trum of antibiotics may also have an impact on the
development of resistance, with broad-spectrum antibiotics
exerting a higher ecological pressure.6
Whether a reduction in antibiotic consumption leads to a
reduction in resistance rates is still a matter of debate and
seems to depend on the microorganisms and antibiotics tested.
While most studies were performed in the hospital setting,
where infection control measures could have influenced the
results, some studies demonstrated the reversibility of resistance
development following reduction in antibiotic consumption in the
ambulatory setting.7 – 11 As antibiotic prescriptions in ambulatory
care exceed antibiotic use in hospitals,1 improving antibiotic pre-
scription in the ambulatory setting might be even more important
in stopping or reversing the increasing antibiotic resistance rates in
the ambulatory setting, and indirectly in the hospital setting.
Using the Swiss Sentinel Surveillance Network of physicians,12
we performed a cluster-randomized intervention study to analyse
the influence of detailed antibiotic prescription guidelines on pre-
scription behaviour. The intervention aimed to simultaneously
reduce antibiotic prescription rates and modify the antibiotics
used in the two most important infections [upper RTIs and
uncomplicated lower urinary tract infections (UTIs)]. To improve
and sustain the impact of the intervention, guidelines were com-
bined with iterative regular feedback on individual prescription
behaviour over 2 years.
Methods
Study design and data collection
This open, prospective, cluster-randomized intervention study was per-
formed within the framework of the Swiss Sentinel Surveillance Network
(https://www.sentinella.ch), covering 3.1% of all Swiss practitioners in pri-
mary care.12
Antibiotic prescription data were collected on a weekly basis by the
Swiss Federal Office of Public Health (SFOH) from 1 January 2011 to 31
December 2012. Antibiotic prescriptions were categorized into penicillins
(including combinations with penicillinase inhibitors), cephalosporins,
macrolides, trimethoprim/sulfamethoxazole, quinolones, tetracyclines,
glycopeptides, oxazolidinones and other. Diseases were categorized into
upper RTIs (including streptococcal angina, otitis media, sinusitis, acute
bronchitis, other upper RTIs), lower RTIs [including exacerbated COPD
(eCOPD) and pneumonia] and lower uncomplicated UTIs. For each anti-
biotic prescription, we collected the following dataset: patient age, gender,
previous antibiotic therapy since November of the preceding year,
perceived patient’s attitude to antibiotic prescription (‘insistent’, ‘not
insistent’), disease category and the antibiotic group prescribed. In the
case of multiple prescriptions only the first prescription per patient and
year was analysed. Incomplete datasets were queried continuously by
the SFOH, were therefore rare and were removed from the dataset (in
total four were missing for ‘indication’ and five were missing for ‘antibiotic
class’).
Baseline characteristics of each practice were obtained by a separate
questionnaire before the start of the study. In an additional survey in
the same practices during 4 weeks in spring and 4 weeks in autumn
each year, we collected data on the total number of cases with sinusitis
or other upper RTIs.
At the end of the study all data were delivered by the SFOH to the
Clinical Trials Unit Bern, University of Bern, in Excel format. The study
was registered at ClinicalTrials.gov (NCT01358916) and was exempted
by the ethics committee from the need to obtain patients’ informed con-
sent because treatment followed current guidelines.
Participants
All registered sentinel members as of May 2010 were evaluated for partici-
pation in this study. We excluded (i) members of the programme commit-
tee and (ii) non-regularly reporting members, defined as members not
reporting at least one physician–patient contact in at least 75% of the
weeks from August 2009 to July 2010. Finally, 140 members were
included and randomly allocated to either the control or the intervention
group in a 1:1 ratio.
Intervention
The intervention consisted of two activities: guidelines for antibiotic pre-
scription in RTIs and UTIs, which were developed by the Pediatric
Infectious Disease Group of Switzerland and—for adult patients—by an
ad hoc committee of adult infectious disease specialists. Guidelines
included indications for antibiotic use as well as information on the pre-
ferred antibiotic regimen (see Supplementary data, available at JAC
Online). The main focus of the guidelines was to restrict prescriptions to
bacterial infections and to preferentially prescribe narrow-spectrum anti-
biotics, namely penicillins for RTIs and trimethoprim/sulfamethoxazole for
uncomplicated lower UTIs. Physicians allocated to the intervention group
received these guidelines in November 2010 and again in April 2012. In
addition they were provided twice yearly with a reminder, including indi-
vidual feedback on their antibiotic prescription pattern for all four primary
and secondary endpoints, compared with the aggregated data of the
other members of the intervention group.
Aim of the study and outcome measures
With this study we aimed to analyse whether an intervention at physician
level would be able to influence the prescription pattern of the individual
physicians. The primary objectives were: (i) to increase the percentage of
prescriptions of penicillins for upper and lower RTIs over all upper and lower
RTIs treated with antibiotics; and (ii) to increase the percentage of tri-
methoprim/sulfamethoxazole prescriptions for uncomplicated lower
UTIs over all uncomplicated lower UTIs in adults (≥17 years) treated
with antibiotics. The secondary objectives were: (i) to decrease the per-
centage of quinolone prescriptions for eCOPD over all eCOPD in adults
(≥17 years) treated with antibiotics; and (ii) to decrease the percentage
of antibiotic prescriptions for sinusitis and other upper RTIs over all diag-
nosed sinusitis and other upper RTIs.
In addition, we evaluated the primary and secondary objectives
at practice level and studied the influence of patient factors (age, gender,
attitude to antibiotic prescription) and practice level factors [practice
type (one versus more than one physician), practice specialization and
language region (French/Italian- versus German-speaking part of
Switzerland)] on the effect of the intervention concerning the primary
and secondary outcomes. Additional pre-specified objectives were defined
and are summarized in the Supplementary data.
Randomization and blinding
Stratified randomization was performed to randomly allocate the prac-
tices to the intervention or control arm in a 1:1 ratio. Variables used for
stratification were practice specialization (paediatric versus internal or
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general), size of cluster (≤100 versus .100 prescriptions per year) and
baseline performance of prescription of penicillins for RTIs (≤50% versus
.50%) based on data collected between August 2009 and July 2010.
Practices were not blinded to allocation.
Statistical analysis
We performed an initial power analysis based on data collected for 1 year
before study start, which was updated 9 months after study start. Based
on 16863 cases with RTIs and 4245 cases with lower UTIs per year, base-
line proportions of 46.6% and 18.9% and intra-class correlations of 0.28
and 0.37, we calculated a power of 0.99 and 0.92 to detect an increase
in the proportion of penicillin prescriptions to 60% and an increase in the
proportion of trimethoprim/sulfamethoxazole prescriptions to 30%,
respectively, with a two-sided type I error of 0.05. Exact details of the
power calculation are given in the Supplementary data.
Outcomes at patient level were analysed using mixed-effects logistic
models that take into account the correlation of data within practices.
Adjustment was done for all stratification factors used in the randomization
procedure. The influence of other co-factors on the intervention effect was
studied by stratified analyses incorporating an interaction term between the
co-factor and the intervention into the mixed-effects logistic model.
To compare prescription rates averaged at practice level, we excluded
practices with fewer than five cases in total. Absolute differences concern-
ing the proportions of the prescriptions for the study drug between the two
groups were derived from linear regression models, adjusting for all strati-
fication factors used in the randomization. We assessed the goodness of
fit of linear regression models by R2. Goodness of fit of mixed-effects logis-
tics models was investigated by plotting deviance residuals against pre-
dicted values. The resulting graphs revealed no extreme observations. A
more detailed description of the regression analyses is provided in the
Supplementary data. In the primary analysis, we used the full analysis
set, including all practices as randomized (ITT principle). In sensitivity ana-
lyses, we used different adjustment schemes as well as a PP analysis set,
where data from practices joining the programme committee of the study
during the study, leaving the Sentinel network within 12 months from the
start of data collection or notifying ,20 prescriptions in total were
excluded.
All endpoint definitions and statistical methods were pre-defined in a
statistical analysis plan before evaluation of the data and strictly followed
during analysis. For the analysis of the primary and secondary endpoints,
the data analyst was blinded to the intervention assignment. Once the pri-
mary and secondary endpoints were analysed, the data analyst was
unblinded. All analyses were done using Stata 12 (Stata Corporation,
College Station, TX, USA).
Results
Practice and patient flow
Between randomization and the start of data collection, three
practices from the control group (4.3%) and one practice from
the intervention group (1.4%) left the sentinel network.
Therefore, 67 practices were finally analysed in the control
group and 69 in the intervention group.
During the study period, a total of 34682 antibiotic prescrip-
tions were collected. Two thousand seven hundred and twenty-
six (17%) out of 16053 prescriptions in the control group and
3004 (16%) out of 18629 prescriptions in the intervention group
were excluded from analysis because antibiotics had been pre-
scribed previously, leaving 13327 and 15625 prescriptions for
analysis in the control and intervention groups, respectively. The
average number (SD) of prescriptions per practice was 199 (156)
and 226 (201) in the control and intervention groups, respectively.
Baseline characteristics
Baseline characteristics of included practices and patients are
shown in Table 1.
There were only minor differences between the control and the
intervention groups.
Primary objectives
The percentage of prescriptions of penicillins for all treated RTIs
was significantly higher in the intervention group [OR 1.42 (95%
CI 1.08–1.89); Table 2]. This difference was mainly driven by a
high increase in the French/Italian-speaking part of Switzerland
[from 35% to 63%, OR 2.81 (95% CI 1.78–4.45)], whereas
prescription rates did not differ between groups in the
Table 1. Baseline characteristics
Control Intervention
Practice characteristics
total, n 67 69
practice specialization
(paediatric versus internal or
general), n (%)
8 (11.9) 9 (13.0)
practice size (.100
prescriptions per year at
baseline), n (%)
41 (61.2) 40 (58.0)
high rate of prescription of
penicillins at baseline (.50%
for RTIs), n (%)
32 (47.8) 31 (44.9)
group practice (.1 physician
per practice), n (%)
28 (41.8) 26 (37.7)
French/Italian-speaking
south-western part of
Switzerland (versus
German-speaking
north-eastern part), n (%)
24 (35.8) 22 (31.9)
Patient characteristics
total, n 13327 15625
age, years, median (IQR) 38 (12–61) 33 (10–58)
age category, years, n (%)
0–5 2041 (15.3) 2486 (15.9)
6–16 1709 (12.8) 2665 (17.1)
17–64 6690 (50.2) 7483 (47.9)
≥65 2887 (21.7) 2991 (19.1)
female, n (%) 8024 (60.2) 9273 (59.3)
insisting on antibiotics, n (%) 1790 (13.4) 1847 (11.8)
indication, n (%)
angina 1976 (14.8) 2736 (17.5)
otitis media 1920 (14.4) 1817 (11.6)
sinusitis 1572 (11.8) 1637 (10.5)
other upper RTIs 1874 (14.1) 2397 (15.3)
acute bronchitis 1868 (14.0) 2211 (14.2)
COPD exacerbation 451 (3.4) 524 (3.4)
pneumonia 799 (6.0) 891 (5.7)
lower UTIs 2867 (21.5) 3412 (21.8)
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German-speaking part of Switzerland (Table 3). The effect of the
intervention tended to be smaller in paediatric than in general/
internal practices. Interestingly, the effect of intervention was sig-
nificantly larger in children than in adults. This also held true
when looking separately at general and internal practices
(P value for interaction¼0.002) or paediatric practices (P value
for interaction¼0.05).
The percentage of trimethoprim/sulfamethoxazole prescrip-
tions for all treated uncomplicated lower UTIs in adults was also
significantly higher in the intervention group [OR 2.16 (95%
CI 1.19–3.91); Table 2]. Again the difference was much higher in
the French/Italian-speaking part of Switzerland [6.8% versus 35%,
OR 5.91 (95% CI 2.05–17.00)] than in the German-speaking part
of Switzerland [28% versus 36%, OR 1.35 (95% CI 0.68–2.66);
Table 4].
Secondary objectives
The percentage of quinolone prescriptions for eCOPD in adults did
not differ between groups (Table 2). There were no differences
between different subgroups of region, gender, practice type or
attitude (data not shown). Analysis of averaged proportions at
practice level revealed congruent results (Table 5 and Figure 1).
Antibiotics were prescribed in about one-third of all patients
with sinusitis or other upper RTIs, irrespective of the group
(Table 5).
Sensitivity analysis
We repeated the main analysis (i) without any adjustment, (ii)
adjusting additionally for age and gender and (iii) using the PP
analysis set. All of these additional analyses led to results very
similar to those of the main analysis (data not shown).
Discussion
In this cluster-randomized trial, antibiotic prescription guidelines
and regular feedback on individual prescription behaviour resulted
in an increase in the use of penicillins for upper RTIs and
Table 3. Comparison of penicillin prescription rate for RTIs among subgroups
Total number OR (95% CI)a P valuea Graph
Overall 22673 1.42 (1.08–1.89)
.5 1 2 4 8
Age 0–16 years 8583 1.88 (1.35–2.62) 0.001
≥17 years 14090 1.32 (0.99–1.76)
Gender male 10573 1.35 (1.01–1.80) 0.13
female 12100 1.48 (1.11–1.97)
Insisting on antibiotics no 19773 1.41 (1.06–1.88) 0.44
yes 2900 1.53 (1.10–2.13)
Paediatric practice no 15821 1.55 (1.15–2.09) 0.12
yes 6852 0.81 (0.38–1.74)
Group practice no 15046 1.37 (0.96–1.97) 0.75
yes 7627 1.51 (0.96–2.36)
Region German 14213 0.99 (0.71–1.37) ,0.001
French/Italian 8460 2.81 (1.78–4.45)
aCalculated from a mixed-effects logistic model with a P value for interaction.
Table 2. Comparison of antibiotic prescription rates between the intervention group and the control group
Control Intervention
ICC OR (95% CI) P value
total number of patients
treated with antibiotics %
total number of patients
treated with antibiotics %
Prescriptions of penicillins
for RTIs (%)
10460 48.5 12213 56.7 0.27 1.42 (1.08–1.89) 0.01
Prescriptions of SXT for
lower UTIs in adults (%)
2744 18.8 3217 35.1 0.44 2.16 (1.19–3.91) 0.01
Prescriptions of quinolones
for COPD exacerbation in
adults (%)
450 4.7 522 4.8 0.50 1.02 (0.36–2.88) 0.96
ICC, intra-class correlation; SXT, trimethoprim/sulfamethoxazole.
Proportions, ICCs, ORs and P values were derived from a mixed-effects logistic model.
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trimethoprim/sulfamethoxazole for uncomplicated lower UTIs,
but did not affect the total amount of antibiotics prescribed for
sinusitis or other upper RTIs. This is in agreement with other stud-
ies, demonstrating that using printed material and feedback for
physician education was not able to improve their prescribing or
only improved it by a small amount, whereas patient-based inter-
ventions or even more multifaceted interventions could reduce
antibiotic prescribing.13 – 15 In general, active clinical education
strategies seem to be more efficient than passive strategies,13,16
and training in enhanced communication skills could be one
important element of these strategies.17,18 In addition, the effect
of even complex intervention programmes may depend on the
infections studied.19
Our intervention was successful in (i) increasing the percentage
of prescriptions of penicillins for all RTIs treated with antibiotics,
paralleled by a decrease in cephalosporin use, while macrolide
consumption was stable, and (ii) increasing the percentage of tri-
methoprim/sulfamethoxazole prescriptions for all uncomplicated
lower UTIs treated with antibiotics, paralleled by a decrease in the
quinolone prescription rate. For both indications, the increase was
significantly more pronounced in the French/Italian-speaking
region of Switzerland, which is known to have higher outpatient
antibiotic prescription rates than the German-speaking part of
Switzerland.20,21
In RTIs, the intervention was more effective in children. There is
some indication that the intervention was less effective in paedi-
atric practices than in general or internal practices; however, the
difference was non-significant (P value for interaction¼0.12). Two
hypotheses may explain this difference. First, as amoxicillin syrup
is widely used in all paediatric practices for RTIs, as reflected by an
amoxicillin prescription rate for RTIs of 82.1% in the control group,
improvement in this subgroup is hardly possible, also taking into
account the contraindications, namely allergic reactions. Second,
the paediatric guidelines existed before this study began. They
were not advertised in the control group, but nevertheless were
available on the internet, which might have further reduced the
effect of the intervention.
Prescription of quinolones for lower RTIs in adults should only
be considered when there are clinically relevant bacterial resist-
ance rates against all first-choice agents.11 Nevertheless, we
were not able to reduce quinolone use in COPD exacerbations.
We suppose that this is due to the already very low quinolone pre-
scription rate and the relative low number of patients in this group.
So far, antibiotic stewardship programmes have mainly been
recommended for hospitals. For outpatient care only a few re-
commendations are offered, largely because of the paucity of
data regarding effective interventions.22 There are few studies
describing the effect of an outpatient antimicrobial stewardship
Table 4. Comparison of trimethoprim/sulfamethoxazole prescription rate for uncomplicated lower UTIs in adults among subgroups
Total number OR (95% CI)a P valuea Graph
Overall 5961 2.16 (1.19–3.91)
.5 1 2 4 8
Gender male 1032 2.41 (1.21–4.77) 0.48
female 4929 2.10 (1.14–3.86)
Insisting on antibiotics no 5238 2.23 (1.23–4.04) 0.23
yes 723 1.69 (0.83–3.44)
Group practice no 3825 2.17 (1.00–4.72) 0.97
yes 2136 2.12 (0.83–5.41)
Region German 4466 1.35 (0.68–2.66) 0.02
French/Italian 1495 5.91 (2.05–17.00)
aCalculated from a mixed-effects logistic model with a P value for interaction.
Table 5. Comparison of antibiotic prescription rates at practice level
Control Intervention
Difference in proportion
(95% CI)a P valueatotal (n) % total (n) %
Prescribing rate of penicillins for RTIs treated with antibiotics 67 48.7 68 55.8 8.0 (2.3–13.6) 0.006
Prescribing rate of SXT for lower UTIs in adults treated with
antibiotics (internal/general practices only)
57 26.4 55 39.0 12.4 (3.3–21.6) 0.009
Quinolone prescribing rate for COPD exacerbation in adults treated with
antibiotics (internal/general practices only)
28 10.5 33 13.3 2.2 (27.6–12.1) 0.66
Prescription rate for all diagnosed sinusitis and other upper RTIs 66 34.4 67 32.5 21.2 (210.5–8.2) 0.80
SXT, trimethoprim/sulfamethoxazole.
aAbsolute differences between groups and corresponding CI and P values were derived from a linear regression model adjusting for all stratification
factors used in the randomization. The goodness of fit of the models, expressed as R2, was 0.48, 0.05, 0.05 and 0.02 from top to bottom.
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intervention on the selection of the preferred antibiotic. In a cross-
sectional study Bhattacharyya et al.14 observed an increase in the
proportion of patients treated with amoxicillin as the agent of
choice from 8.1% to 29.4% after publication of treatment guide-
lines for sinusitis in adults. In another study22—using a 1 h educa-
tion session, quarterly audits and regular feedback as intervention
tools—broad-spectrum prescriptions for RTIs in a paediatric popu-
lation were reduced from 26.8% to 14.3%, which compares well
with the absolute increase in prescription of penicillins of 13.4% in
patients below age 17 in our study.
Our study has several strengths. Randomization was done by
practice and there were no significant differences between the
groups. Data analysis proved to be very stable, as ITT analysis,
PP analysis and analysis at practice and patient levels all led to
congruent results.
There were some limitations in our study. First, practices were
not blinded to allocation and practices participating in the sentinel
network are probably not representative of all Swiss physicians.
However, we believe that the high interest of study physicians in
infectious diseases and knowledge of the study design probably
led to better results in the control group, which would rather
underestimate the effect of our study. Second, the cluster-
randomized design did not allow prescription patterns to be stud-
ied within individual practices. Third, we do not have any data on
the duration of therapy or the DDDs used. Fourth, we were not able
to identify which part of the intervention was most effective. Fifth,
we did not analyse whether outcomes were different between
groups, although there are some data in the literature showing
that outcomes and satisfaction of patients are not influenced
by the prescription pattern.16,18 Sixth, we did not measure the sus-
tainability of the effect, but there is some evidence that effects
may be sustained for years.17 Seventh, as participants did not
cover a complete geographical region, we were not able to
study the effect of this intervention on resistance prevalence.
We conclude that publication of guidelines and individual feed-
back to prescribers may influence prescription behaviour. It may
be easier to modify the preferred antibiotic than the total anti-
biotic prescription rate. Knowledge of the size of the effect in indi-
vidual subgroups is important for better targeting of further
interventions.
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